Literature DB >> 18789772

Role of the coagulation system in allergic inflammation in the upper airways.

Shino Shimizu1, Takeshi Shimizu, John Morser, Tetsu Kobayashi, Aiko Yamaguchi, Liqiang Qin, Masaaki Toda, Corina D'Alessandro-Gabazza, Takaya Maruyama, Takehiro Takagi, Yutaka Yano, Yasuhiro Sumida, Tatsuya Hayashi, Yoshiyuki Takei, Osamu Taguchi, Koji Suzuki, Esteban C Gabazza.   

Abstract

Thrombin has been detected and demonstrated to play a role in the airways of patients with bronchial asthma, but its role in the upper airways including during allergic rhinitis is unknown. This study was conducted to explore whether thrombin is presence in the upper airways and, if so, whether it affects mucin secretion. Fifteen patients with allergic rhinitis were enrolled in the clinical study; primary nasal septum epithelial cells and normal bronchial epithelial cells were used for in vitro evaluation, and rats as animal models. Significant concentrations of thrombin were found in nasal secretion after allergic provocation in allergic patients, and thrombin and its agonistic receptor peptide induced significant secretion of mucin in primary nasal cells and normal bronchial epithelial cells as compared to non-stimulated cells. Increased mucosubstance secretion in septum epithelial cells was also induced after nasal instillation of thrombin in rats. Further, the anticoagulant, activated protein C, significantly inhibited thrombin-induced mucin secretion from septum epithelial cells in rats. The results of this study suggest that activation of the coagulation system occurs during the allergic response and that thrombin plays a crucial role in the regulation of mucin production in the upper airways.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18789772     DOI: 10.1016/j.clim.2008.07.020

Source DB:  PubMed          Journal:  Clin Immunol        ISSN: 1521-6616            Impact factor:   3.969


  9 in total

1.  Role of thrombin-activatable fibrinolysis inhibitor in allergic bronchial asthma.

Authors:  Atsushi Fujiwara; Osamu Taguchi; Takehiro Takagi; Corina N D'Alessandro-Gabazza; Daniel Boveda-Ruiz; Masaaki Toda; Atsushi Yasukawa; Yuki Matsushima; Yasushi Miyake; Hiroyasu Kobayashi; Tetsu Kobayashi; Paloma Gil-Bernabe; Masahiro Naito; Masamichi Yoshida; John Morser; Yoshiyuki Takei; Esteban C Gabazza
Journal:  Lung       Date:  2011-10-25       Impact factor: 2.584

2.  Receptor-promoted exocytosis of airway epithelial mucin granules containing a spectrum of adenine nucleotides.

Authors:  Silvia M Kreda; Lucia Seminario-Vidal; Catharina A van Heusden; Wanda O'Neal; Lisa Jones; Richard C Boucher; Eduardo R Lazarowski
Journal:  J Physiol       Date:  2010-04-26       Impact factor: 5.182

Review 3.  Mechanisms and pathogenesis of chronic rhinosinusitis.

Authors:  Atsushi Kato; Robert P Schleimer; Benjamin S Bleier
Journal:  J Allergy Clin Immunol       Date:  2022-03-01       Impact factor: 14.290

Review 4.  The protein C pathway in tissue inflammation and injury: pathogenic role and therapeutic implications.

Authors:  Silvio Danese; Stefania Vetrano; Li Zhang; Victoria A Poplis; Francis J Castellino
Journal:  Blood       Date:  2009-12-17       Impact factor: 22.113

Review 5.  The roles of thrombin and protease-activated receptors in inflammation.

Authors:  Liang Ma; Anthony Dorling
Journal:  Semin Immunopathol       Date:  2011-08-02       Impact factor: 9.623

Review 6.  Chronic Rhinosinusitis and the Coagulation System.

Authors:  Dong Young Kim; Seong H Cho; Tetsuji Takabayashi; Robert P Schleimer
Journal:  Allergy Asthma Immunol Res       Date:  2015-05-12       Impact factor: 5.764

7.  Allergic rhinitis is associated with thromboembolic disease in pregnancy.

Authors:  Chia-Ta Wu; Chien-Han Tsao; Kuan-Ting Chen; Yu-Tzu Lee; Min-Sho Ku
Journal:  Sci Rep       Date:  2022-05-04       Impact factor: 4.996

Review 8.  The Role of Platelet-Derived Extracellular Vesicles in Immune-Mediated Thrombosis.

Authors:  Alicia S Eustes; Sanjana Dayal
Journal:  Int J Mol Sci       Date:  2022-07-16       Impact factor: 6.208

Review 9.  Thrombin Inhibition by Argatroban: Potential Therapeutic Benefits in COVID-19.

Authors:  Kholoud F Aliter; Rami A Al-Horani
Journal:  Cardiovasc Drugs Ther       Date:  2020-09-01       Impact factor: 3.947

  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.